Regencell Bioscience Holdings Ltd RGC:NASDAQ

RT Quote | USD
Last | 03/27/24 EDT
3.47quote price arrow up+0.02 (+0.58%)
Volume
744
52 week range
3.16 - 31.30
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close3.45
  • 52 Week High31.30
  • 52 Week High Date04/20/23
  • 52 Week Low3.16
  • 52 Week Low Date03/26/24

Key Stats

  • Market Cap45.155M
  • Shares Out13.01M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta-0.24
  • YTD % Change-66.95

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close3.45
  • 52 Week High31.30
  • 52 Week High Date04/20/23
  • 52 Week Low3.16
  • 52 Week Low Date03/26/24
  • Market Cap45.155M
  • Shares Out13.01M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta-0.24
  • YTD % Change-66.95

RATIOS/PROFITABILITY

  • EPS (TTM)-0.45
  • P/E (TTM)-7.69
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-7.618M
  • ROE (TTM)-113.96%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Regencell Bioscience Holdings Ltd

 

Profile

MORE
Regencell Bioscience Holdings Ltd is a bioscience company that focuses on research, development and commercialization of traditional Chinese medicine (TCM) for the treatment of neurocognitive disorders and degeneration, specifically attention deficit and hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). The Company launches three liquid based standardized TCM formulae candidates for mild, moderate and severe ADHD and ASD patients.
Address
11/F First Commercial Building
33-35 Leighton Roa
999077
Hong Kong